{'text': 'Novartis heart failure medicine Entresto™ substantially cuts 30-day hospital readmissions, new post-hoc analysis shows', 'publisher': {'href': 'https://www.prnewswire.com', 'title': 'PR Newswire'}, 'created_at': 'Tue, 10 Nov 2015 08:00:00 GMT', 'description': 'Novartis heart failure medicine Entresto™ substantially cuts 30-day hospital readmissions, new post-hoc analysis shows  PR Newswire', 'url': 'https://news.google.com/rss/articles/CBMiggJBVV95cUxNOEcxdGdXYk1iOVZ6WFViX2hwVVZvbEpmc0NEWG00YVR2eXQ3TjZ1WklCT296eDhYbU5hZXl1TXU3WktwWFVDNUtXT1dZMFYzNFE2MzJpam83ZG5vcGdKN2RvYmxFRnJ5WTVyMnVWME94Rnp1SEx1azBZaDM1Xzd2ZGtUNXB6WXRiU29PVnpidE44QzNGMXl0VmZhMy1ScUZwLTREQTRYUGw0VFp4N042enBWQVpqSGFyLWtBZURsd2oxNzQ4aTRpQ2NoUk9BSVFiNTlqT1J5QU5sM2tKLVloSUFNNTRnRFNoOVdCQ21HQmxNTk5LSmZSdHp2SS1xRU9UM1E?oc=5&hl=en-US&gl=US&ceid=US:en'}
